News


( Last Updated : March 7, 2015)

December 1, 2021
The expansion of digital health over the past 18 months has been nothing short of remarkable. But as our reliance on these health technologies grows, so too does the need for evidence to guide decisions about how, when, and where they can be used most effectively. In celebration of Digital Health…
November 29, 2021
A new analysis of prescription drug expenditures found that total prescription drug purchases in Canada in 2020 reached $32.7 billion, an increase of 4.3% from the previous year. Additionally, over the past 20 years this spending has grown at an average annual rate of 6%, three times the average…
November 25, 2021
The CADTH Therapeutic Review of treatments for transplant-ineligible multiple myeloma patients represents several firsts for the organization. It is CADTH’s first therapeutic review in oncology, and its first involving international collaboration. It also showcases many of the progressive aspects…
November 4, 2021
Today CADTH published new recommendations that offer advice to pan-Canadian health systems on how to implement remote monitoring programs for patients with chronic cardiac conditions. These recommendations emphasize patient, caregiver, and provider considerations, data and privacy, digital equity,…
October 8, 2021
Suzanne McGurn, President and CEO of CADTH, is pleased to announce the appointment of new members of the CADTH Canadian Drug Expert Committee (CDEC) and the CADTH pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC), as well as a new chair and new members of the Health…